XML 25 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Note 9 - Preferred Stock
9 Months Ended
Sep. 30, 2019
Notes to Financial Statements  
Preferred Stock [Text Block]
9.
Preferred Stock
 
Prefer
red Stock
Summary
 
We are authorized to issue up to
10,000,000
shares of our Preferred Stock,
$.01
par value, which
may
be issued in
one
or more series. The table below presents our issued and outstanding series of preferred stock as of
September 30, 2019
and
December 31, 2018.
Each series of our outstanding preferred stock has a stated value of
$1,000
per share. Further details concerning each series of preferred stock, and the changes in each series during the
three
-month and
nine
-month periods ending
September 30, 2019
and
2018
are discussed in the sections that follow the table.
 
   
September 30, 2019
   
December 31, 2018
 
           
Carrying
           
Carrying
 
   
Shares
   
Value
   
Shares
   
Value
 
Series B Convertible Preferred Stock
   
100
    $
76,095
     
100
    $
76,095
 
Series C Convertible Preferred Stock
   
-
     
-
     
2,150
     
705,238
 
Series E Convertible Preferred Stock
   
-
     
-
     
1,200
     
1,190,000
 
Series H Convertible Preferred Stock
   
2,254
     
1,545,728
     
-
     
-
 
Series I Convertible Preferred Stock
   
700
     
700,000
     
-
     
-
 
Total
   
3,054
    $
2,321,823
     
3,450
    $
1,971,333
 
 
Series B Preferred Stock
 
During the
nine
-month period ended
September 
30,
2019,
there were
no
conversions or other transactions involving our Series B Convertible Preferred Stock (“Series B Preferred Stock”). As of
September 30, 2019,
there are
100
shares of our Series B Convertible Preferred Stock outstanding. The Series B Preferred Stock
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price of
$175
per share.
 
Series
C
Preferred Stock
 
During
January
and
February 2019,
587
shares of our Series C Convertible Preferred Stock (“Series C Preferred Stock”) were converted into
78,280
shares of our common stock. As discussed below, during
February 2019,
all remaining shares of Series C Preferred Stock (
1,563
shares) were exchanged for Series F Preferred Stock.
 
Series
E
Preferred Stock
 
During the
nine
-month period ended
September 
30,
2019,
there were
no
conversions involving our Series E Convertible Preferred Stock (“Series E Preferred Stock”). As discussed below, during
February 2019,
all remaining shares of Series E Preferred Stock (
1,200
shares) were exchanged for Series F Preferred Stock.
 
Series F Preferred Stock
 
On
February 18, 2019,
we entered into Exchange Agreements with holders of our Series C and Series E Preferred Stock, pursuant to which the holders exchanged all shares of Series C and Series E Preferred Stock held by them for an aggregate of
2,763
shares of Series F Convertible Preferred Stock (“Series F Preferred Stock”). Each share of Series F Preferred Stock is entitled to a liquidation preference equal to its
$1,000
stated value, has
no
voting rights, and is
not
entitled to a dividend. The Series F Preferred Stock is convertible at any time at the option of the holders into shares of our common stock, at a conversion price equal to the lesser of (i)
$7.50
per share and (ii)
90%
of the volume weighted average price of the common stock immediately preceding the delivery of a notice of conversion. The Series F Preferred Stock contains price adjustment provisions, which
may,
under certain circumstances reduce the conversion price to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the then conversion price of the Series F Preferred Stock. During the
three
-month and
nine
-month periods ending
September 30, 2019,
46
and
507
shares, respectively, of Series F Preferred Stock were converted into
88,400
and
381,700
shares, respectively, of our common stock. As discussed below, during
July 2019,
all remaining shares of Series F Preferred Stock (
2,256
shares) were exchanged for Series H Preferred Stock.
 
Series G Preferred Stock
 
On
February 25, 2019,
we entered into a Securities Purchase Agreement with the purchasers identified therein (the “Purchasers”) providing for sale to the Purchasers of an aggregate of up to
1,000
shares of our Series G Convertible Preferred Stock (“Series G Preferred Stock”) and related warrants for gross proceeds of up to
$1.0
million, which was funded at
three
different closings. Each share of Series G Preferred Stock is entitled to a liquidation preference equal to its
$1,000
stated value, has
no
voting rights, and is
not
entitled to a dividend. The Series G Preferred Stock is convertible at any time at the option of the holders into shares of our common stock, at a conversion price equal to the lesser of (i)
$7.50
per share and (ii)
90%
of the volume weighted average price of the common stock immediately preceding the delivery of a notice of conversion. The Series G Preferred Stock contains price adjustment provisions, which
may,
under certain circumstances reduce the conversion price to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the then conversion price of the Series G Preferred Stock.
 
At the
first
closing, which occurred on
February 26, 2019,
we issued
500
shares of Series G Preferred Stock in exchange for the payment by the Purchasers of
$250,000
in the aggregate, plus the cancellation of Term Notes held by the Purchasers (see Note
7
) in the amount of
$250,000.
At the
first
closing we also issued warrants to purchase an aggregate of
33,334
shares of our common stock. The warrants have an initial exercise price of
$7.50
per share, are exercisable
six
months from the issuance date, and have a term of exercise equal to
five
years from the date they
first
become exercisable. The warrants contain anti-dilution and price adjustment provisions, which
may,
under certain circumstances reduce the exercise price to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the then exercise price of the warrants; in the event of such adjustment, the number of shares subject to the warrants will also increase so that the aggregate exercise price remains the same for each warrant. At the
second
and
third
closings, which occurred on
April 26
and
June 19, 2019,
we issued an aggregate of
500
additional shares of Series G Preferred Stock in exchange for the payment by the Purchasers of a total of
$500,000
.
We also issued the Purchasers warrants to purchase an aggregate of
66,668
shares of our common stock. As discussed below, during
July 2019,
all of the then-outstanding shares of Series G Preferred Stock (
1,000
shares) were exchanged for Series H Preferred Stock.
 
Series H Preferred Stock
 
On
July 16, 2019,
we entered into Exchange Agreements with holders of our Series F and Series G Preferred Stock, pursuant to which the holders exchanged all shares of Series F and Series G Preferred Stock held by them for an aggregate of
3,256
shares of Series H Convertible Preferred Stock (“Series H Preferred Stock”). Each share of Series H Preferred Stock is entitled to a liquidation preference equal to its
$1,000
stated value, has
no
voting rights, and is
not
entitled to a dividend. The Series H Preferred Stock is convertible at any time at the option of the holders into shares of our common stock, at a conversion price equal to the lesser of (i)
$7.50
per share and (ii)
80%
of the lowest volume weighted average price of the Common Stock during the
ten
trading days immediately preceding the delivery of a notice of conversion. The Series H Preferred Stock contains price adjustment provisions, which
may,
under certain circumstances reduce the conversion price to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the then conversion price of the Series H Preferred Stock. During the
three
-month period ending
September 30, 2019,
1,002
shares of Series H Preferred Stock were converted into
94,687,441
shares of our common stock. As of
September 30, 2019,
there are
2,254
shares of our Series H Preferred Stock outstanding, which
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price determined based on the calculation described above.
 
Series I Preferred Stock
 
On
July 24, 2019,
we entered into a Securities Purchase Agreement with the purchasers identified therein (the “Purchasers”) providing for sale to the Purchasers of an aggregate of
700
shares of our Series I Convertible Preferred Stock (“Series I Preferred Stock”) for gross proceeds of
$700,000.
Each share of Series I Preferred Stock is entitled to a liquidation preference equal to its
$1,000
stated value, has
no
voting rights, and is
not
entitled to a dividend. The Series I Preferred Stock is convertible at any time at the option of the holders into shares of our common stock, at a conversion price equal to the lesser of (i)
$7.50
per share and (ii)
80%
of the lowest volume weighted average price of the Common Stock during the
ten
trading days immediately preceding the delivery of a notice of conversion. The Series I Preferred Stock contains price adjustment provisions, which
may,
under certain circumstances reduce the conversion price to match if we sell or grant options to purchase, including rights to reprice, our common stock or common stock equivalents at a price lower than the then conversion price of the Series I Preferred Stock. During the
three
-month period ended
September 
30,
2019,
there were
no
conversions involving our Series I Preferred Stock. As of
September 30, 2019,
there are
700
shares of our Series I Preferred Stock outstanding, which
may
be converted at any time at the option of the holder into shares of our common stock at a conversion price determined based on the calculation described above